Clinical Trial Update: Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing two topical corticosteroid regimens to prevent corneal graft rejection after Descemet membrane endothelial keratoplasty (DMEK); results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bullous Keratopathy
• Fuchs Endothelial Dystrophy

Drugs mentioned

• Corticosteroid regimen A (topical) (topical corticosteroid)
• Corticosteroid regimen B (topical) (topical corticosteroid)

Snippet

Sponsor: Price Vision Group | Conditions: Fuchs' Dystrophy, Bullous Keratopathy | Phase 2 | Status: COMPLETED | Results posted: 2014-08-25